1. Home
  2. EVO vs EIKN Comparison

EVO vs EIKN Comparison

Compare EVO & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.58

Market Cap

895.8M

Sector

Health Care

ML Signal

HOLD

EIKN

Eikon Therapeutics Inc. Common Stock

N/A

Current Price

$9.90

Market Cap

731.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVO
EIKN
Founded
1993
2019
Country
Germany
United States
Employees
4766
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.8M
731.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
EIKN
Price
$2.58
$9.90
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$7.00
$25.60
AVG Volume (30 Days)
107.5K
312.8K
Earning Date
05-05-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$9.46
52 Week High
$4.80
$16.50

Technical Indicators

Market Signals
Indicator
EVO
EIKN
Relative Strength Index (RSI) 45.13 37.39
Support Level $2.32 $9.46
Resistance Level $3.82 $16.34
Average True Range (ATR) 0.07 1.14
MACD 0.05 -0.10
Stochastic Oscillator 98.11 14.34

Price Performance

Historical Comparison
EVO
EIKN

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: